USPTO Issues CBD Trademark Guidelines in Light of the 2018 Farm Bill: Key Takeaways -
On May 2, 2019, the USPTO released its new guidelines on how it will examine federal trademark applications for CBD products in light of...more
6/6/2019
/ Cannabidiol (CBD) oil ,
Controlled Substances Act ,
Copyright ,
Design Patent ,
Due Diligence ,
Farm Bill ,
Food and Drug Administration (FDA) ,
IP License ,
Lanham Act ,
Licenses ,
Licensing Rules ,
Open Source Software ,
Patent Ownership ,
Patent Validity ,
Patents ,
Software ,
Software Patents ,
Trademarks ,
USPTO
Under U.S. law, design patents cover the ornamental design of an object having practical utility. Accordingly, in a design patent application, the subject matter claimed is the design embodied in or applied to an article of...more
Avoiding Common IP Pitfalls: What Every Startup Needs to Know -
Startup companies often face significant risk and liability with respect to Intellectual Property (IP) on their path to success. The failure to adequately...more
In the wake of the ongoing Apple v. Samsung saga, design patents are becoming increasingly popular as an additional or alternative mechanism to protect inventions. This article focuses on drafting and prosecuting U.S. design...more
On January 10, 2013, the Federal Circuit in InterDigital Communications v. ITC denied a combined petition for panel rehearing and for rehearing en banc, holding that InterDigital’s patent licensing alone met the domestic...more
In This Issue:
Federal Courts Debate Safe Harbor Exemption for Patent Infringement Under 35 U.S.C. § 271(e) Following Merck v. Integra; If I Prioritize Examination of My Application, Should the Patent Office?;...more
2/19/2013
/ Biotechnology ,
Discovery ,
Exemptions ,
Food and Drug Administration (FDA) ,
Hatch-Waxman ,
Infringement ,
Integra ,
InterDigital Communications v ITC ,
Merck ,
Non-Practicing Entities ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Prioritized Examination ,
Safe Harbors